TIDAGIXAGENE DERXEPARVOVEC
UNII Y7ARS22SWQ

Substance Identification & Data

This profile provides standardized clinical and technical data for Tidagixagene Derxeparvovec, uniquely identified by the FDA Unique Ingredient Identifier (UNII) Y7ARS22SWQ.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2644621-85-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
Y7ARS22SWQ
CAS Registry Number
2644621-85-0
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
TIDAGIXAGENE DERXEPARVOVEC
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C190499
National Cancer Institute reference terminology for clinical and research data.
INN ID
12310
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
structurallyDiverse
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Tidagixagene Derxeparvovec. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

TIDAGIXAGENE DERXEPARVOVEC

Common Names & Synonyms

DNA (RECOMBINANT ADENO-ASSOCIATED VIRUS 9 VECTOR TSHA-120 SYNTHETIC JET PROMOTER PLUS HUMAN GIGAXONIN TRANSGENE PLUS SYNTHETIC POLYADENYLATION SIGNAL PLUS ADENO-ASSOCIATED VIRUS 2 INVERTED TERMINAL REPEAT FLANKS-SPECIFYING)
RECOMBINANT, SELF-COMPLEMENTARY (DIMERIC), NON-REPLICATING ADENO-ASSOCIATED VIRUS SEROTYPE 9 (SCAAV9) VECTOR ENCODING CODON-OPTIMISED HUMAN GIGAXONIN (GIANT AXONAL NEUROPATHY (GAN) GENE, KELCH-LIKE PROTEIN 16) UNDER THE CONTROL OF THE ARTIFICIAL JET PROMOTER (BUILT FROM FRAGMENTS OF THE VIRAL SIMIAN VIRUS 40 (SV40) EARLY PROMOTER AND THE HUMAN BETA-ACTIN AND UBIQUITIN C PROMOTERS), TERMINATED BY A SYNTHETIC POLYADENYLATION SEQUENCE, AND FLANKED BY AAV2 INVERTED TERMINAL REPEATS (ITRS)
TIDAGIXAGENE DERXEPARVOVEC [INN]
TSHA-120

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus